摘要
目的探讨Omi/HtrA2基因启动子-958C/G单核苷酸多态性(SNP)与帕金森病(PD)的关系。方法采用病例一对照研究,选择56例PD患者(病例组)和109例健康体检者(对照组)为对象,应用聚合酶链反应一限制性酶切片段长度多态性分析方法(PCR—RFLP)检测Omi/HtrA2基因启动子958C/G单核苷酸多态性,并分析其基因型及等位基因频率在正常人群及PD患者中的分布特点。结果Omi/HtrA2基因启动子SNP-958C/G在病例组中C等位基因频率为75.0%,对照组为84.4%,两组比较差异有统计学意义(P〈0.05);病例组CC基因型为53.6%,对照组为69.7%,两组比较差异有统计学意义(P〈0.05)。结论Omi/HtrA2基因启动子SNP一958C/G与PD相关,C等位基因及CC基因型对PD可能是保护性因素。
Objective To investigate the frequency distribution of single-nucleotide polymorphisms(SNP) of Omi/HtrA2 gene promoter -958C/G, and the relationship between these polymorphism and Parkinson' s disease (PD). Methods By using a case-control method, 56 PD patients ( the case group) and 109 healthy controls( the control group) were selected in the study. The SNP of -958C/G of Omi/HtrA2 gene was identified by the polymerase chain reaction(PCR) and restriction fragment length polymorphism(RFLP) ,and genotype and allele frequency distributions in normal people and PD patients were analyzed. Results The C allele frequency of Omi/HtrA2 gene SNP-958C/G was 75.0% in the case group, and which in the control group was 84.4%. The difference was significant( P 〈 0.05 ) ;In PD, CC genotyping frequencies was 53.6%, and that in controls was 69.7%. The difference was also significant (P 〈 0.05). Conclusion Omi/HtrA2 gene SNP-958C/G was associated with PD, C allele and CC genotype might be the protective factor of PD patients.
出处
《临床内科杂志》
CAS
2012年第4期243-245,共3页
Journal of Clinical Internal Medicine
基金
广东省医学科研基金资助项目A2007453